New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - budesonide 160ug equivalent to 200 µg metered dose;  ;  ;  ; formoterol fumarate 4.5ug equivalent to 6 µg metered dose;   - powder for inhalation - active: budesonide 160ug equivalent to 200 µg metered dose       formoterol fumarate 4.5ug equivalent to 6 µg metered dose   excipient: lactose monohydrate - symbicort turbuhaler is indicated in the treatment of asthma to achieve overall asthma control, including the prevention and relief of symptoms as well as the reduction of the risk of exacerbations. symbicort turbuhaler is suitable for any asthma severity, where the use of inhaled corticosteroids is appropriate.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - budesonide; formoterol fumarate dihydrate - inhalation powder - 400microgram/1dose ; 12microgram/1dose

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - budesonide; formoterol fumarate dihydrate - powder, metered - 160 mcg/dose - budesonide 160 mcg/dose; formoterol fumarate dihydrate 4.5 mcg/dose

Singapore - English - HSA (Health Sciences Authority)

astrazeneca singapore pte ltd - budesonide; formoterol fumarate dihydrate - powder, metered - 80 mcg/dose - budesonide 80 mcg/dose; formoterol fumarate dihydrate 4.5 mcg/dose

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - budesonide; formoterol fumarate dihydrate - inhalation powder - 200microgram/1dose ; 6microgram/1dose

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - budesonide 80ug;  ;  ;  ; formoterol fumarate 4.5ug;   - aerosol inhaler, metered dose - 100/6 - active: budesonide 80ug       formoterol fumarate 4.5ug   excipient: apaflurane macrogol 1000 povidone - symbicort rapihaler 100/6 is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate. this includes: · patients who are not adequately controlled with inhaled corticosteroid therapy and ?as needed? inhaled short-acting beta-2 adrenoceptor agonists. · patients who are already adequately controlled on regular separate long acting beta-agonist and inhaled corticosteroid therapies.

New Zealand - English - Medsafe (Medicines Safety Authority)

astrazeneca limited - budesonide 160ug;  ;  ;  ; formoterol fumarate 4.5ug;   - aerosol inhaler, metered dose - 200/6 - active: budesonide 160ug       formoterol fumarate 4.5ug   excipient: apaflurane macrogol 1000 povidone - symbicort rapihaler 100/6 is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate. this includes: · patients who are not adequately controlled with inhaled corticosteroid therapy and ?as needed? inhaled short-acting beta-2 adrenoceptor agonists. · patients who are already adequately controlled on regular separate long acting beta-agonist and inhaled corticosteroid therapies.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

astrazeneca uk ltd - budesonide; formoterol fumarate dihydrate - inhalation powder - 100microgram/1dose ; 6microgram/1dose

Malta - English - Medicines Authority

aa-pharma ul. sapiezynska 10, 00-215 warsawa, poland - budesonide, formoterol - inhalation powder - budesonide 400 microgram(s) ; formoterol 12 microgram(s) - drugs for obstructive airway diseases

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

astrazeneca sdn. bhd. - budesonide; formoterol fumarate -